CHRONIC VENOUS THROMBOSIS: RELIEF WITH ADJUNCTIVE CATHETER-DIRECTED THERAPY
Are you eligible to participate in this study?
You may be eligible for this study if you meet the following criteria:
-
Conditions: Chronic Dvt
-
Age: Between 18 Year(s) - 99 Year(s)
-
Gender: Male or Female
-
Other Inclusion Criteria:
- Disabling (moderate-to-severe) PTS, defined by a) presence of chronic venous disease > 3 months duration in a leg with a history of DVT, as determined by the site principal investigator or a physician co-investigator; and b) either a Venous Clinical Severity Score (VCSS) > 8 or a Villalta PTS Scale score > 10 or an open venous ulcer);
- Ipsilateral iliac vein obstruction (occlusion or > 50% diameter stenosis), documented by traditional venogram, CT venogram, MR venogram, or intravascular ultrasound (IVUS) within the previous 1 month and after any endovascular procedure (if applicable).
You may not be eligible for this study if the following are true:
-
- Acute proximal DVT episode within the last 3 months
- Lack of suitable inflow into the common femoral vein (CFV) per the treating physician
- Documented obstruction (occlusion or > 50% diameter stenosis) of an IVC filter
- Chronic arterial limb ischemia (ankle-brachial index < 0.5 within the previous 1 month)
- Presence of open venous ulcer > 50 cm2 area, or suspicion for active ulcer infection
- Inability to tolerate endovascular procedure due to acute illness or general health
- Severe allergy to iodinated contrast refractory to steroid premedication
- Known allergy to stent or catheter components
- Hemoglobin < 8.0 g/dl, uncorrectable INR > 3.0 or platelet count < 75,000/ml
- Severe renal impairment (on chronic dialysis or estimated GFR < 30 ml/min)
- Disseminated intravascular coagulation or other major bleeding diathesis
- Pregnancy (positive pregnancy test)
- Life-expectancy < 6 months or chronically non-ambulatory for reasons other than PTS
- Inability to provide informed consent or to comply with study assessments.
If you are registered as a volunteer, please log in to contact the study team/express interest in this study.